CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ADAPTIVE PLATFORM TRIAL DESIGNS BASED ON THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGhT) EXPERIENCE

Rifaquat Rahman; Lorenzo Trippa; Eudocia Quant Lee; Isabel Arrillaga-Romany; Mehdi Touat; Geffrey Fell; Christine McCluskey; Jennifer Bruno; Sarah Gaffey; Jan Drappatz; Andrew Lassman; Evanthia Galanis; Manmeet Ahluwalia; Howard Colman; L Burt Nabors; Jaroslaw Hepel; Heinrich Elinzano; David Schiff; Ugonma Chukwueke; Rameen Beroukhim; Tracy Batchelor; Lakshmi Nayak; J Ricardo McFaline-Figueroa; Mikael Rinne; Thomas Kaley; Christine Lu-Emerson; Wenya Linda Bi; Omar Arnaout; Daphne Haas-Kogan; Shyam Tanguturi; Daniel Cagney; Ayal Aizer; Mary Welch; Lisa Doherty; Maria Lavallee; Brittany Fisher-Longden; Shanna Dowling; William Pisano; Emily Lapinskas; David Meredith; E Antonio Chiocca; David Reardon; Keith Ligon; Brian Alexander; Patrick Wen

doi:10.1093/NEUONC/NOAB196.265

CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ADAPTIVE PLATFORM TRIAL DESIGNS BASED ON THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGhT) EXPERIENCE

Rifaquat Rahman
, Lorenzo Trippa
, Eudocia Quant Lee
, Isabel Arrillaga-Romany
, Mehdi Touat
, Geffrey Fell
, Christine McCluskey
, Jennifer Bruno
, Sarah Gaffey
, Jan Drappatz
, Andrew Lassman
, Evanthia Galanis
, Manmeet Ahluwalia
, Howard Colman
, L Burt Nabors
, Jaroslaw Hepel
, Heinrich Elinzano
, David Schiff
, Ugonma Chukwueke
, Rameen Beroukhim

Tracy Batchelor, Lakshmi Nayak, J Ricardo McFaline-Figueroa, Mikael Rinne, Thomas Kaley, Christine Lu-Emerson, Wenya Linda Bi, Omar Arnaout, Daphne Haas-Kogan, Shyam Tanguturi, Daniel Cagney, Ayal Aizer, Mary Welch, Lisa Doherty, Maria Lavallee, Brittany Fisher-Longden, Shanna Dowling, William Pisano, Emily Lapinskas, David Meredith, E Antonio Chiocca, David Reardon, Keith Ligon, Brian Alexander, Patrick Wen

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	23
DOIs	https://doi.org/10.1093/NEUONC/NOAB196.265
State	Published - Nov 12 2021

Disciplines

Medicine and Health Sciences
Oncology
Internal Medicine

Access to Document

10.1093/NEUONC/NOAB196.265License: Unspecified

Cite this

Rahman, R., Trippa, L., Lee, E. Q., Arrillaga-Romany, I., Touat, M., Fell, G., McCluskey, C., Bruno, J., Gaffey, S., Drappatz, J., Lassman, A., Galanis, E., Ahluwalia, M., Colman, H., Nabors, L. B., Hepel, J., Elinzano, H., Schiff, D., Chukwueke, U., ... Wen, P. (2021). CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ADAPTIVE PLATFORM TRIAL DESIGNS BASED ON THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGhT) EXPERIENCE. Neuro-oncology, 23. https://doi.org/10.1093/NEUONC/NOAB196.265

Rahman, R, Trippa, L, Lee, EQ, Arrillaga-Romany, I, Touat, M, Fell, G, McCluskey, C, Bruno, J, Gaffey, S, Drappatz, J, Lassman, A, Galanis, E, Ahluwalia, M, Colman, H, Nabors, LB, Hepel, J, Elinzano, H, Schiff, D, Chukwueke, U, Beroukhim, R, Batchelor, T, Nayak, L, McFaline-Figueroa, JR, Rinne, M, Kaley, T, Lu-Emerson, C, Bi, WL, Arnaout, O, Haas-Kogan, D, Tanguturi, S, Cagney, D, Aizer, A, Welch, M, Doherty, L, Lavallee, M, Fisher-Longden, B, Dowling, S, Pisano, W, Lapinskas, E, Meredith, D, Chiocca, EA, Reardon, D, Ligon, K, Alexander, B & Wen, P 2021, 'CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ADAPTIVE PLATFORM TRIAL DESIGNS BASED ON THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGhT) EXPERIENCE', Neuro-oncology, vol. 23. https://doi.org/10.1093/NEUONC/NOAB196.265

@article{3bc25dd695f8438a9f792e3c62ea80ea,

title = "CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ADAPTIVE PLATFORM TRIAL DESIGNS BASED ON THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGhT) EXPERIENCE",

author = "Rifaquat Rahman and Lorenzo Trippa and Lee, \{Eudocia Quant\} and Isabel Arrillaga-Romany and Mehdi Touat and Geffrey Fell and Christine McCluskey and Jennifer Bruno and Sarah Gaffey and Jan Drappatz and Andrew Lassman and Evanthia Galanis and Manmeet Ahluwalia and Howard Colman and Nabors, \{L Burt\} and Jaroslaw Hepel and Heinrich Elinzano and David Schiff and Ugonma Chukwueke and Rameen Beroukhim and Tracy Batchelor and Lakshmi Nayak and McFaline-Figueroa, \{J Ricardo\} and Mikael Rinne and Thomas Kaley and Christine Lu-Emerson and Bi, \{Wenya Linda\} and Omar Arnaout and Daphne Haas-Kogan and Shyam Tanguturi and Daniel Cagney and Ayal Aizer and Mary Welch and Lisa Doherty and Maria Lavallee and Brittany Fisher-Longden and Shanna Dowling and William Pisano and Emily Lapinskas and David Meredith and Chiocca, \{E Antonio\} and David Reardon and Keith Ligon and Brian Alexander and Patrick Wen",

note = "You do not currently have access to this article. Subscription prices and ordering for this journal Don't already have an Oxford Academic account? Register CTNI-40.",

year = "2021",

month = nov,

day = "12",

doi = "10.1093/NEUONC/NOAB196.265",

language = "American English",

volume = "23",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ADAPTIVE PLATFORM TRIAL DESIGNS BASED ON THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGhT) EXPERIENCE

AU - Rahman, Rifaquat

AU - Trippa, Lorenzo

AU - Lee, Eudocia Quant

AU - Arrillaga-Romany, Isabel

AU - Touat, Mehdi

AU - Fell, Geffrey

AU - McCluskey, Christine

AU - Bruno, Jennifer

AU - Gaffey, Sarah

AU - Drappatz, Jan

AU - Lassman, Andrew

AU - Galanis, Evanthia

AU - Ahluwalia, Manmeet

AU - Colman, Howard

AU - Nabors, L Burt

AU - Hepel, Jaroslaw

AU - Elinzano, Heinrich

AU - Schiff, David

AU - Chukwueke, Ugonma

AU - Beroukhim, Rameen

AU - Batchelor, Tracy

AU - Nayak, Lakshmi

AU - McFaline-Figueroa, J Ricardo

AU - Rinne, Mikael

AU - Kaley, Thomas

AU - Lu-Emerson, Christine

AU - Bi, Wenya Linda

AU - Arnaout, Omar

AU - Haas-Kogan, Daphne

AU - Tanguturi, Shyam

AU - Cagney, Daniel

AU - Aizer, Ayal

AU - Welch, Mary

AU - Doherty, Lisa

AU - Lavallee, Maria

AU - Fisher-Longden, Brittany

AU - Dowling, Shanna

AU - Pisano, William

AU - Lapinskas, Emily

AU - Meredith, David

AU - Chiocca, E Antonio

AU - Reardon, David

AU - Ligon, Keith

AU - Alexander, Brian

AU - Wen, Patrick

N1 - You do not currently have access to this article. Subscription prices and ordering for this journal Don't already have an Oxford Academic account? Register CTNI-40.

PY - 2021/11/12

Y1 - 2021/11/12

UR - https://academic.oup.com/neuro-oncology/article-abstract/23/Supplement_6/vi68/6426876

U2 - 10.1093/NEUONC/NOAB196.265

DO - 10.1093/NEUONC/NOAB196.265

M3 - Article

VL - 23

JO - Neuro-oncology

JF - Neuro-oncology

ER -

CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ADAPTIVE PLATFORM TRIAL DESIGNS BASED ON THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGhT) EXPERIENCE

Disciplines

Access to Document

Other files and links

Cite this